News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BrainStorm Cell Therapeutics Inc. Announces Pricing of Underwritten Public Offering


8/13/2013 10:08:38 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK & PETAH TIKVA, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) today announced the pricing of a $4.0 million underwritten public offering of 23,529,411 units at a public offering price of $0.17 per unit, with each unit consisting of one share of its common stock, par value $0.00005 per share, and 0.75 of a warrant to purchase one share of its common stock at an exercise price of $0.25 per share. The offering is expected to close on August 16, 2013 subject to customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES